Comparison of the fluorescein angiography-guided and indocyanine green angiography-guided photodynamic therapy in the treatment of non-resolving central serous chorioretinopathy

• Published in: Scientific reports Vol. 13; no. 1; p. 1682
• Main Authors: Ebrahimiadib, Nazanin, Mirzaei, Arash, Esfandiarifard, Shaghayegh, Tuli, Sonal, Najibzadeh, Ehsan, Imani Fooladi, Marjan, Fadakar, Kaveh
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 30.01.2023; Nature Publishing Group; Nature Portfolio
• Subjects: 692/308; 692/699; 692/699/3161; Acuity; Angiography; Central Serous Chorioretinopathy - diagnostic imaging; Central Serous Chorioretinopathy - drug therapy; Chronic Disease; Fluorescein; Fluorescein Angiography; Humanities and Social Sciences; Humans; Indocyanine Green; Medical imaging; multidisciplinary; Photochemotherapy; Photodynamic therapy; Photosensitizing Agents - therapeutic use; Porphyrins; Prospective Studies; Retrospective Studies; Science; Science (multidisciplinary); Tomography, Optical Coherence; Verteporfin - therapeutic use
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-023-28890-9

To compare the functional and anatomical outcome of fluorescein angiography (FA) versus indocyanine green angiography (ICGA) guided photodynamic therapy (PDT) in the treatment of non-resolving central serous chorioretinopathy (CSCR). In this prospective interventional case series, all patients with non-resolving CSCR, defined as persistent SRF involving subfoveal area for at least three months, were nonrandomly assigned to receive either FA or ICGA-guided half dose PDT. Baseline and 4 months post-treatment data including best corrected visual acuity (BCVA), the status of foveal subretinal fluid, subfoveal choroidal thickness, choroidal vascularity index, pigment epithelial detachment area, treatment and PDT spot numbers were collected. Thirty-six eyes were included; 24 received ICGA-guided and 12 received FA-guided PDT. Overall, improvement in BCVA and choroidal parameters were observed in all patients. There was no significant difference in baseline parameters as well as follow-up measurements between groups. However, the mean total energy dose and spot number in the IGCA-guided PDT were significantly higher than the FA-guided PDT group ( P  = 0.001). Both FA-guided and ICGA-guided half-dose PDT were effective in the treatment of non-resolving CSCR, with favorable functional and anatomical outcome. In FA group, PDT with smaller spot sizes and fewer numbers of spots were applied.